Evidence map›Paper›PMID 14966287›Full record

ArticleMolecular and cellular biology2004

Id2 is dispensable for Myc-induced epidermal neoplasia.

Daniel J Murphy, Lamorna Brown Swigart, Mark A Israel, Gerard I Evan

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel J MurphyCancer Research Institute, University of California at San Francisco, San Francisco, California 94143-0875, USA.
Lamorna Brown Swigart
Mark A Israel
Gerard I Evan
Cancer Research Institute · USCotton (United States) · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Anaplasia &differentiation in a reversible cancer modelF32CA099363 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MURPHY, DANIEL J · 2003 to 2005
$152k
NCI NIH HHS 1 F32 CA99363-01NCI NIH HHS 5P30 CA23108-24NCI NIH HHS F32 CA099363NCI NIH HHS P30 CA023108
6 · The paper itself

Abstract

We have previously described a transgenic mouse model of epidermal neoplasia wherein expression of a switchable form of c-Myc, MycER(TAM), is targeted to the postmitotic suprabasal keratinocytes of murine epidermis via the involucrin promoter. Sustained activation of c-MycER(TAM) results in a progressive neoplastic phenotype characterized by aberrant ectopic proliferation and delayed differentiation of suprabasal keratinocytes, culminating in papillomatosis. Transcription of the Id2 gene is regulated by Myc family proteins. Moreover, Id2 is implicated as a pivotal determinant of cell fate in multiple lineages and has a demonstrated role in mediating Myc-dependent cell proliferation in vitro through its interaction with retinoblastoma protein. Using Id2 nullizygous mice, we assessed in vivo the requirement for Id2 in mediating Myc-induced papilloma formation in skin. We show that absence of Id2 has no discernible impact on any measurable attribute of Myc function or on the timing or extent of eventual tumor formation. Thus, our data argue against any essential role for Id2 in mediating Myc action in vivo.

Indexed as

Repressor ProteinsAnimalsCell DifferentiationDNA-Binding ProteinsEpidermal CellsEpidermisInhibitor of Differentiation Protein 1Inhibitor of Differentiation Protein 2In Situ HybridizationKeratinocytesMiceMice, Inbred C57BLMice, KnockoutNeovascularization, PathologicPapillomaProto-Oncogene Proteins c-mycDNA-Binding ProteinsIdb1 protein, mouseIdb2 protein, mouseInhibitor of Differentiation Protein 1Inhibitor of Differentiation Protein 2Proto-Oncogene Proteins c-mycRepressor ProteinsTranscription Factors

Identifiers

PMID14966287
PMCPMC350569
OpenAlexW2118505322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.